We conclude that CD4+ and CD8+ cells in thoracic and abdominal aortic aneurysm samples showed distinct transition trajectories and subsets and displayed distinct inflammatory and gene transcriptional situations, indicating that targeted treatment strategies should be taken into consideration for the therapy of TAA and AAA. This evidence concerns the gene CD4 and triple-A syndrome.